{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T10:25:03Z","timestamp":1790418303926,"version":"4.1.0"},"reference-count":23,"publisher":"American Society of Hematology","issue":"16","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8,24]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Germline RUNX1 mutations underlie a syndrome, RUNX1-familial platelet disorder (RUNX1-FPD), characterized by bleeding symptoms that result from quantitative and\/or qualitative defect in platelets and a significantly increased risk for developing hematologic malignancies. Myeloid neoplasms are the most commonly diagnosed hematologic malignancies, followed by lymphoid malignancies of T-cell origin. Here, we describe the first 2 cases of B-cell acute lymphoblastic leukemia (B-ALL) in patients with confirmed germline RUNX1 mutations. While 1 of the patients had a known diagnosis of RUNX1-FPD with a RUNX1 p.P240Hfs mutation, the other was the index patient of a kindred with a novel RUNX1 variant, RUNX1 c.587C&amp;gt;T (p.T196I), noted on a targeted genetic testing of the B-ALL diagnostic sample. We discuss the clinical course, treatment approaches, and the outcome for the 2 patients. Additionally, we describe transient resolution of the mild thrombocytopenia and bleeding symptoms during therapy, as well as the finding of clonal hematopoiesis with a TET2 mutant clone in 1 of the patients. It is critical to consider testing for germline RUNX1 mutations in patients presenting with B-ALL who have a personal or family history of thrombocytopenia, bleeding symptoms, or RUNX1 variants identified on genetic testing at diagnosis.<\/jats:p>","DOI":"10.1182\/bloodadvances.2021004653","type":"journal-article","created":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T15:47:49Z","timestamp":1629733669000},"page":"3199-3202","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":16,"title":["B-cell acute lymphoblastic leukemia in patients with germline <i>RUNX1<\/i> mutations"],"prefix":"10.1182","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3927-2743","authenticated-orcid":false,"given":"Kathryn A.","family":"Six","sequence":"first","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Gerdemann","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Hospital Cancer and Blood Disorders Center, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-0138","authenticated-orcid":false,"given":"Anna L.","family":"Brown","sequence":"additional","affiliation":[{"name":"Department of Genetics and Molecular Pathology, SA Pathology, Centre for Cancer Biology, SA Pathology and University of South Australia, School of Medicine, University of Adelaide, Adelaide, SA, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9604-4213","authenticated-orcid":false,"given":"Andrew E.","family":"Place","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Hospital Cancer and Blood Disorders Center, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan B.","family":"Cantor","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Hospital Cancer and Blood Disorders Center, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Kutny","sequence":"additional","affiliation":[{"name":"Division of Hematology\/Oncology, Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serine","family":"Avagyan","sequence":"additional","affiliation":[{"name":"Dana-Farber\/Boston Children\u2019s Hospital Cancer and Blood Disorders Center, Boston, MA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"issue":"2","key":"2021082315372633400_B1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/13793","article-title":"Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia","volume":"23","author":"Song","year":"1999","journal-title":"Nat Genet."},{"issue":"1","key":"2021082315372633400_B2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1182\/blood.2019000937","article-title":"Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA)","volume":"136","author":"Brown","year":"2020","journal-title":"Blood."},{"issue":"6","key":"2021082315372633400_B3","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1182\/bloodadvances.2019000901","article-title":"RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML","volume":"4","author":"Brown","year":"2020","journal-title":"Blood Adv."},{"issue":"5","key":"2021082315372633400_B4","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/j.1365-2141.2010.08370.x","article-title":"Childhood B-cell precursor acute lymphoblastic leukaemia in a patient with familial thrombocytopenia and RUNX1 mutation","volume":"151","author":"Linden","year":"2010","journal-title":"Br J Haematol."},{"issue":"1","key":"2021082315372633400_B5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/0165-4608(94)90208-9","article-title":"Presenting characteristics of trisomy 8 as the primary cytogenetic abnormality associated with childhood acute lymphoblastic leukemia. A Pediatric Oncology Group (POG) Study (8600\/8493)","volume":"75","author":"Pettenati","year":"1994","journal-title":"Cancer Genet Cytogenet."},{"issue":"4","key":"2021082315372633400_B6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.jmoldx.2016.02.003","article-title":"Validation and Implementation of a custom next-generation sequencing clinical assay for hematologic malignancies","volume":"18","author":"Kluk","year":"2016","journal-title":"J Mol Diagn."},{"issue":"7","key":"2021082315372633400_B7","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.clml.2016.04.001","article-title":"Evaluation of patients and families with concern for predispositions to hematologic malignancies within the hereditary hematologic malignancy clinic (HHMC)","volume":"16","author":"DiNardo","year":"2016","journal-title":"Clin Lymphoma Myeloma Leuk."},{"issue":"18","key":"2021082315372633400_B8","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1182\/blood-2015-09-670166","article-title":"EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications","volume":"127","author":"Schwab","year":"2016","journal-title":"Blood."},{"issue":"20","key":"2021082315372633400_B9","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/bloodadvances.2019000644","article-title":"ClinGen Myeloid Malignancy Variant Curation Expert Panel recommendations for germline RUNX1 variants","volume":"3","author":"Luo","year":"2019","journal-title":"Blood Adv."},{"issue":"1","key":"2021082315372633400_B10","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13023-016-0432-0","article-title":"Haematological spectrum and genotype-phenotype correlations in nine unrelated families with RUNX1 mutations from the French network on inherited platelet disorders","volume":"11","author":"Latger-Cannard","year":"2016","journal-title":"Orphanet J Rare Dis."},{"issue":"4","key":"2021082315372633400_B11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/leu.2015.236","article-title":"Somatic mutations associated with leukemic progression of familial platelet disorder with predisposition to acute myeloid leukemia","volume":"30","author":"Antony-Debr\u00e9","year":"2016","journal-title":"Leukemia."},{"issue":"2","key":"2021082315372633400_B12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1053\/j.seminhematol.2017.04.006","article-title":"RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukemia, FPDMM)","volume":"54","author":"Schlegelberger","year":"2017","journal-title":"Semin Hematol."},{"issue":"10","key":"2021082315372633400_B13","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3324\/haematol.2016.146316","article-title":"Whole exome sequencing identifies genetic variants in inherited thrombocytopenia with secondary qualitative function defects","volume":"101","author":"Johnson","year":"2016","journal-title":"Haematologica."},{"issue":"15","key":"2021082315372633400_B14","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1182\/blood-2016-10-687830","article-title":"Role of RUNX1 in hematological malignancies","volume":"129","author":"Sood","year":"2017","journal-title":"Blood."},{"issue":"12","key":"2021082315372633400_B15","first-page":"1985","article-title":"TEL\/AML1 fusion resulting from a cryptic t(12;21) is the most common genetic lesion in pediatric ALL and defines a subgroup of patients with an excellent prognosis","volume":"9","author":"Shurtleff","year":"1995","journal-title":"Leukemia."},{"issue":"3","key":"2021082315372633400_B16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1182\/blood-2013-01-480244","article-title":"Runx1 is essential at two stages of early murine B-cell development","volume":"122","author":"Niebuhr","year":"2013","journal-title":"Blood."},{"issue":"7","key":"2021082315372633400_B17","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood-2006-02-002188","article-title":"A critical role for the transcription factor Scl in platelet production during stress thrombopoiesis","volume":"108","author":"McCormack","year":"2006","journal-title":"Blood."},{"issue":"1","key":"2021082315372633400_B18","doi-asserted-by":"crossref","first-page":"30255","DOI":"10.1038\/srep30255","article-title":"NF-E2, FLI1 and RUNX1 collaborate at areas of dynamic chromatin to activate transcription in mature mouse megakaryocytes","volume":"6","author":"Zang","year":"2016","journal-title":"Sci Rep."},{"issue":"3","key":"2021082315372633400_B19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1182\/bloodadvances.2020002709","article-title":"Restoring RUNX1 deficiency in RUNX1 familial platelet disorder by inhibiting its degradation","volume":"5","author":"Krutein","year":"2021","journal-title":"Blood Adv."},{"issue":"1","key":"2021082315372633400_B20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1182\/blood-2015-03-631747","article-title":"Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes","volume":"126","author":"Steensma","year":"2015","journal-title":"Blood."},{"issue":"22","key":"2021082315372633400_B21","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2015-04-641100","article-title":"Genomic analysis of germline and somatic variants in familial myelodysplasia\/acute myeloid leukemia","volume":"126","author":"Churpek","year":"2015","journal-title":"Blood."},{"issue":"24","key":"2021082315372633400_B22","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1200\/JCO.19.00181","article-title":"Stopping leukemia in its tracks: should preemptive hematopoietic stem-cell transplantation be offered to patients at increased genetic risk for acute myeloid leukemia?","volume":"37","author":"Hamilton","year":"2019","journal-title":"J Clin Oncol."},{"issue":"2","key":"2021082315372633400_B23","first-page":"99","article-title":"Role of RUNX family transcription factors in DNA damage response","volume":"43","author":"Samarakkody","year":"2020","journal-title":"Mol Cells."}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/16\/3199\/1818953\/advancesadv2021004653.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/5\/16\/3199\/1818953\/advancesadv2021004653.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,23]],"date-time":"2021-08-23T15:48:08Z","timestamp":1629733688000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/5\/16\/3199\/476596\/B-cell-acute-lymphoblastic-leukemia-in-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":23,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2021,8,24]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2021004653","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]}}}